Cancer prevention

Lancet

Volumn 349, Issue SUPPL.2, 1997, Pages

  Osborne, Michael ^a   Boyle, Peter ^b   Lipkin, Martin ^a,c  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALCOHOL; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; BETA CAROTENE; CALCIUM; CANCER VACCINE; CYCLOOXYGENASE 2 INHIBITOR; EFLORNITHINE; FENRETINIDE; FINASTERIDE; GLYCYRRHETINIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; PIROXICAM; PRASTERONE; RETINOID; RETINOL; SULINDAC; SUNSCREEN; TAMOXIFEN; VITAMIN; VITAMIN D;

ALCOHOL CONSUMPTION; CANCER; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIET; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; HUMAN; LIFESTYLE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; SUN EXPOSURE; TOBACCO; VACCINATION; VIRUS CARCINOGENESIS;

EID: 0030913956     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(97)90018-0     Document Type: Article

References (36)

1. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 39: 1268-78.
2. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Doll R. Mortality from smoking world-wide. Br Med Bull 1996; 52: 12-21.
3. Centres for Disease Control. Smoking-attributable mortality and years of potential life lost-United States, 1988. MMWR 1991; 40: 62-71.
4. USDHHS (United States Department of Health and Human Services). Reducing the health consequences of smoking: 25 years of progress, a report of the Surgeon General. Washington, DC: US Government Printing Office, 1989.
5. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F. Trends of cancer mortality in Europe, 1955-89: II respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer 1992; 28: 514-99.
6. La Vecchia C, Lucchini F, Negri E, Boyle P, Levi F. Trends in cancer mortality in the Americas, 1955-1989. Eur J Cancer 1993; 29A: 431-70.
7. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the recommendations of European Cancer Experts Consensus Meeting. Helsinki, October, 1996. Lung Cancer (in press).
8. IARC (International Agency for Research on Cancer) Monographs on the evaluation of carcinogenic risk to humans: alcohol drinking. Vol 44. Lyon: IARC, 1988.
9. Parkin DM, Ferlay J, Pisani P. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
10. Boyle P, Veronesi U, Tubiana M, et al. European School of Oncology advisory report to the European Commission for the "Europe Against Cancer Programme": European Code Against Cancer. Eur J Cancer 1995; 9: 1395-405.
11. IARC (International Agency for Research on Cancer) monographs on the evaluation of carcinogens to man: human papilloma viruses.Vol XX. Lyon: IARC, 1996.
12. Epstein MA. Epstein-Barr virus - discovery, properties and relationship to nasopharyngeal carcinoma. In: De ThÇ G, Ito Y, eds. Nasopharyngeal carcinoma: etiology and control. Lyon: IARC, Scientific Publication no 20, 1978.
13. Beasley RP, Lin C, Hwang LY and Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981; ii: 1129-33.
14. Biggar RJ, Rosenberg PS, Cote T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS: multistate AIDS/cancer match study. Int J Cancer 1996; 68: 754-58.
15. Pedersen C, Barton SE, Chiesi A, et al. HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. Eur J Haematol 1995; 55: 245-50.
16. Tomatis L, Day NE, Heseltine E, et al. Cancer: causes, occurrence and control. Lyon: IARC, Scientific Publication no 100, 1990.
17. Lipkin M. Strategies for colon cancer prevention. Ann NY Acad Sci 1995; 768: 129-40.
18. Steinmetz K.A., Potter J.D. Vegetable, fruit, and cancer I: epidemiology. Cancer Causes Control 1991; 2: 325-58.
19. Blot WJ, Li J-Y, Taylor P, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483-92.
20. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
21. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-49.
22. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-55.
23. Greenwald P, Clifford C, Pilch S, Heimendinger J, Kelloff G. New directions in dietary studies in cancer: the National Cancer Institute. In: Longnecker JB, et al, eds. Nutrition and biotechnology in heart disease and cancer. New York: Plenum Press, 1995: 229-39.
24. Weisberger JH. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr 1995; 53: 226s.
25. Wattenberg L, Lipkin M, Boone CW, Kelloff G, eds. Chemoprevention of cancer. Boca Raton: CRC Press, 1992.
26. Kelloff G, Boone C, eds. Cancer chemopreventive agents: drug development status and future prospects. J Cell Biochem 1994; S20: 1-303.
27. Buiatti E. Intervention trials of cancer prevention: results and new research programmes. Lyon: IARC Technical Report no 18, 1994.
28. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-31.
29. Hursting S, Thornquist M, Henderson M. Types of dietary fat and the incidence of cancer at five sites. Prev Med 1990; 19: 242-53.
30. Rose D, Goldman M, Connolly J, Strong L. High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr 1991; 54: 520-25.
31. Henderson M, Kushi L, Thompson D, et al. Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial vanguard study. PrevMed 1990; 19: 115-33.
32. White T, Shattuck A, Kristal A, et al. Maintenance of a low-fat diet: follow-up of the Women's Health Trial. Cancer Epidemiol Biomark 1992; 1: 315-22.
33. Omenn G, Goodman G, Thornquist M, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations; smokers and asbestos-exposed workers. Cancer Res 1994; 54: 2038s-43s.
34. Hennekens C. Issues in the design and conduct of clinical trials. J Natl Cancer Inst 1984; 73: 1473-76.
35. Kelloff G, Johnson J, Crowell J, et al. Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol Biomark 1995; 4: 1-10.
36. Kelloff G, Crowell J, Boone C, et al. Strategy and planning for chemopreventive drug development: clinical development plans. J Cell Biochem 1994; S20: 55-299.